A DIGITAL HEALTH INFORMATION JOURNEY

“Empowering and equipping Europeans with health information
for active personal health management and adherence to treatment”
ABOUT US

The Gravitate Health is a public – private partnership with 40 members from Europe and the US, co-led by University of Oslo (coordinator) and Pfizer (industry lead), funded by the Innovative Medicines Initiative (IMI) – a joint undertaking of the European Commission, the European Federation of Pharmaceutical Industries and Associations (EFPIA), IMI2 Associated Partners.

FIND OUT MORE
Mission

The Gravitate Health mission is to equip and empower citizens with digital information tools that make them confident, active, and responsive in their patient journey, specifically encouraging safe use of medicines for better health outcomes and quality of life.

Vision

Engagement of citizens in their own health can only be achieved with access to actionable, understandable, relevant, reliable and evidence-based information that meets their specific needs, health context, and literacy level.

Ambition

To provide a key piece to advance this vision: the Gravitate Lens (G-Lens), which focuses (but does not conceal or filter) approved electronic product information (ePI) content, and offers a route for patients to access trustworthy, up-to-date information that better meet their individual needs.

0
.20
Project Launch
0
mo.
Duration
0
€
Mio Budget
0
Partners
Check the Upcoming Events & Register HERE
ANNOUNCEMENT BOARD
PARTICIPATE
in our events, Connectathons, Hackathons, and more

FIND OUT
ENGAGE with us
ask questions, subscribe to ‘Under the Lens’ newsletter

FIND OUT
FOLLOW US

and share with us your feedback on Twitter

FIND OUT

OUR LATEST news
DHS_2022
20 Sep: 04.10.2022 | DHS Summit | The use of health data for innovation & recovery
Read More
GRAVITATE HEALTH-EMA statement
22 Aug: Statement of collaboration to support the EU ePI Common Standard
Read More
MIMITT2022-eLabeling2
22 Aug: 24.08.2022 | Virtual | Gravitate Health EU-China Workshop
Read More
ALL OUR NEWS
Project Leads

Lorem Ipsum proin gravida nibh vel velit auctor aliquet. Aenean sollicitudin, lorem quis bibendum auctor, nisi elit consequatm proin gravida nibh vel ipsum, nec sagittis sem nibh id elit. Duis sed odio sit amet nibh vulputate cursus a sit amet mauris. Morbi accumsan ipsum velit. Nam nec tellus a odio tincidunt auctor a ornare odio. Sed non mauris vitae erat consequat.

Anne Moen
Giovanna Ferrari
Prof Anne Moen
Coordinator of Gravitate-Health and Professor in the Institute for health and society, University of Oslo

The Personas illustrate key features of the G-lens® functionality to focus health information from trusted sources and change access to relevant information about medication. Personas represent diverse user needs, which is important when interdisciplinary teams approach complex challenges in a dynamic information landscape.

Dr Giovanna Ferrari
Senior Director, Pfizer and Gravitate-Health Project Lead

Our dissemination, communication and stakeholder activities –i.e., establishing a user advisory group, engaging healthcare ecosystems, participating in conferences and HL7 connectathons and more – are strong areas of focus and we believe are key to the long-term sustainability of the Gravitate Health tools and technologies.

...Gravitate Health is an integrated digital health information project.

Gravitate Health services and the G-lens will be developed and tested within the project, using an evaluation framework to test their ability to improve access to & understanding of health information, drive adherence and improve patient outcomes.

MILESTONES
G-lens mock-ups and KPIs
100%
1st version of FOSPS architecture
99%
Concept validation of FOSPS platform and G-lens
65%
Use case prioritizing for real world validation
47%
Gravitate Health FOSPS final version
36%
Gravitate Health Project Duration
33%
PARTNERS

40 partners from all over Europe and the US participate in the project.

ACADEMIA / RESEARCH COMMUNICATION EFPIA & IMI2 PARTNERS HCPs & PAYERS PATIENTS / CONSUMERS REGULATORS STANDARDS / EVALUATION TECHNICAL EXPERTISE
Akershus Universitetssykehus
Akershus Universitetssykehus
in HCPs & PAYERS
AstraZeneca AB
AstraZeneca AB
in EFPIA & IMI2 PARTNERS
Bayer Aktiengesellschaft
Bayer Aktiengesellschaft
in EFPIA & IMI2 PARTNERS
Medicines Evaluation Board – MEB
Medicines Evaluation Board – MEB
in REGULATORS
Datapharm Limited
Datapharm Limited
in EFPIA & IMI2 PARTNERS
Datawizard SRL
Datawizard SRL
in TECHNICAL EXPERTISE
Division of Clinical Informatics at Beth Israel Deaconess Medical Center
Division of Clinical Informatics at Beth Israel Deaconess Medical Center
in HCPs & PAYERS
Eli Lilly and Company Limited
Eli Lilly and Company Limited
in EFPIA & IMI2 PARTNERS
empirica Gesellschaft für Kommunikations-und Technologieforschung mbH
empirica Gesellschaft für Kommunikations-und Technologieforschung mbH
in ACADEMIA / RESEARCH
European Connected Health Alliance
European Connected Health Alliance
in COMMUNICATION
F. Hoffmann – La Roche AG
F. Hoffmann – La Roche AG
in EFPIA & IMI2 PARTNERS
Forum Europeen des Patients (EPF)
Forum Europeen des Patients (EPF)
in PATIENTS / CONSUMERS
FrisQ Holding AB
FrisQ Holding AB
in TECHNICAL EXPERTISE
Grünenthal GmBH
Grünenthal GmBH
in EFPIA & IMI2 PARTNERS
Guardtime OÜ
Guardtime OÜ
in TECHNICAL EXPERTISE
HIMSS Europe GmBH
HIMSS Europe GmBH
in COMMUNICATION
HL7 Europe
HL7 Europe
in STANDARDS / EVALUATION
Karolinska Institutet
Karolinska Institutet
in ACADEMIA / RESEARCH HCPs & PAYERS
Københavns Universitet
Københavns Universitet
in ACADEMIA / RESEARCH
MDSOL Europe Ltd (Medidata)
MDSOL Europe Ltd (Medidata)
in EFPIA & IMI2 PARTNERS
MINDVIEW Business Consulting & Research LTD
MINDVIEW Business Consulting & Research LTD
in COMMUNICATION
Norsk e-Helse AS
Norsk e-Helse AS
in TECHNICAL EXPERTISE
Norwegian Centre for eHealth Research
Norwegian Centre for eHealth Research
in ACADEMIA / RESEARCH
Novartis Pharma AG
Novartis Pharma AG
in EFPIA & IMI2 PARTNERS
PredictBy
PredictBy
in STANDARDS / EVALUATION
Pfizer Limited (Project Lead)
Pfizer Limited (Project Lead)
in EFPIA & IMI2 PARTNERS
Universitet i Oslo (Coordinator)
Universitet i Oslo (Coordinator)
in ACADEMIA / RESEARCH
Serviços Partilhados do Ministério da Saúde, E.P.E.
Serviços Partilhados do Ministério da Saúde, E.P.E.
in HCPs & PAYERS
Statens Legemiddelverk / (Norvegian Medicines Agency – NOMA)
Statens Legemiddelverk / (Norvegian Medicines Agency – NOMA)
in REGULATORS
The European Institute for Innovation through Health Data [i-HD]
The European Institute for Innovation through Health Data [i-HD]
in ACADEMIA / RESEARCH
The Synergist
The Synergist
in COMMUNICATION
Trifork Public A/S
Trifork Public A/S
in TECHNICAL EXPERTISE
Trinity College Dublin
Trinity College Dublin
in ACADEMIA / RESEARCH
UCB Biopharma SRl
UCB Biopharma SRl
in EFPIA & IMI2 PARTNERS
Università Cattolica del Sacro Cuore – EMH
Università Cattolica del Sacro Cuore – EMH
in ACADEMIA / RESEARCH
Viatris
Viatris
in EFPIA & IMI2 PARTNERS
Universidad Politécnica de Madrid (UPM) – LifeSTech
Universidad Politécnica de Madrid (UPM) – LifeSTech
in ACADEMIA / RESEARCH
Servicio Madrileño de Salud
Servicio Madrileño de Salud
in HCPs & PAYERS
University College Dublin (UCD)
University College Dublin (UCD)
in ACADEMIA / RESEARCH
Agencia Española de Medicamentos y Productos Sanitarios
Agencia Española de Medicamentos y Productos Sanitarios
in REGULATORS
Steering Committee

Meet the project’s Steering Committee members…

MartinIngvar_500sq
Martin Ingvar
KI, WP1 Co-Lead
DipakKalra
Dipak Kalra
I~HD, WP6 Co-Lead
MedranoA-n
Alejandro Medrano
UPM, WP3 Co-Lead
Bebbington-Deb-n
Deb Bebbington
Bayer, Regulatory & ePI Lead
more members
SURVEYS

Participate in our surveys for consumers / patients / HCPs…

find out more
Subscribe to our newsletter
Citizens
Policy and regulatory institutions
Researchers
Industry, SMEs / developers
Healthcare providers / professionals
Twitter Feed

You are welcome to contact us for any matter,
just submit the following form.

    Supported by a grant from IMI
    This project has received funding from the Innovative Medicines Initiative 2 Joint Undertaking (JU) under grant agreement No 945334. The JU receives support from the European Union’s Horizon 2020 research and innovation programme, the European Federation of Pharmaceutical Industries and Associations [EFPIA], and Datapharm Limited. The total budget is 18.5M€ for a project duration of 60 months.

    Disclaimer:
    Information on this website reflects Project owner’s views and neither IMI nor the European Union, EFPIA, or or Datapharm Limited are liable for any use that may be made of the information contained herein.